Hogaboom G K, Mong S, Stadel J M, Crooke S T
J Pharmacol Exp Ther. 1985 Jun;233(3):686-93.
[3H]Leukotriene (LT) D4 was used to identify specific LTD4 binding sites in guinea-pig ventricular myocardial membranes. High-performance liquid chromatography analyses indicated that, in the presence of the gamma-glutamyl transpeptidase inhibitor L-serine-borate (80 mM), less than 3% of membrane-bound [3H]LTD4 was converted to [3H]LTC4 or [3H]LTE4 at 30 degrees C. The specific [3H] LTD4 binding, assayed in the presence of 80 mM L-serine-borate, reached a stable steady state within 45 min at 30 degrees C (pH 7.5). A monophasic Scatchard plot of saturation binding data yielded an apparent dissociation constant (Kd) of 3.4 +/- 2.1 nM and a maximum number of binding sites of 850 +/- 91 fmol/mg of protein. Competition binding studies with [3H]LTD4, synthetic 5S, 6R-LTD4 (LTD4) and its diastereoisomer 5R,6S-LTD4, LTE4, LTC4 and the putative LT antagonists FPL 55712, 4R-hydroxy-5S-1-cysteinylglycine-6Z-nonadecanoic acid (2-nor-LTD1) and SKF 88046 demonstrated a potency order of LTD4 greater than LTE4 greater than LTC4 greater than 5R,6S-LTD4 much greater than 2-nor-LTD1. FPL 55712 and SKF 88046 were ineffective in displacing the specific [3H]LTD4 binding. Pretreatment of the heart membranes with the sulfhydryl reducing reagent dithiothreitol decreased the specific [3H]LTD4 binding in a concentration-dependent manner. Scatchard analyses of saturation isotherms indicated that 0.3 mM dithiothreitol pretreatment of heart membranes decreased the maximum number of binding sites of the [3H]LTD4 binding to 368 +/- 61 fmol/mg of protein with minimal effects on the apparent Kd.(ABSTRACT TRUNCATED AT 250 WORDS)
[3H]白三烯(LT)D4用于鉴定豚鼠心室心肌膜中的特异性LTD4结合位点。高效液相色谱分析表明,在γ-谷氨酰转肽酶抑制剂L-丝氨酸-硼酸盐(80 mM)存在下,30℃时膜结合的[3H]LTD4转化为[3H]LTC4或[3H]LTE4的比例不到3%。在80 mM L-丝氨酸-硼酸盐存在下测定的特异性[3H]LTD4结合,在30℃(pH 7.5)下45分钟内达到稳定的稳态。饱和结合数据的单相Scatchard图得出表观解离常数(Kd)为3.4±2.1 nM,最大结合位点数为850±91 fmol/mg蛋白质。用[3H]LTD4、合成的5S,6R-LTD4(LTD4)及其非对映异构体5R,6S-LTD4、LTE4、LTC4以及推定的LT拮抗剂FPL 55712、4R-羟基-5S-1-半胱氨酰甘氨酸-6Z-十九碳烯酸(2-去甲-LTD1)和SKF 88046进行的竞争结合研究表明,LTD4的效力顺序大于LTE4大于LTC4大于5R,6S-LTD4远大于2-去甲-LTD1。FPL 55712和SKF 88046在取代特异性[3H]LTD4结合方面无效。用巯基还原剂二硫苏糖醇预处理心脏膜以浓度依赖性方式降低了特异性[3H]LTD4结合。饱和等温线的Scatchard分析表明,0.3 mM二硫苏糖醇预处理心脏膜使[3H]LTD4结合的最大结合位点数降至368±61 fmol/mg蛋白质,对表观Kd影响最小。(摘要截断于250字)